NAME: Steven R. Goldstein, M.D.€¦ · NAME: Steven R. Goldstein, M.D. BUSINESS ADDRESS: 530 First...

1

CURRICULUM VITAE

NAME: Steven R. Goldstein, M.D.

BUSINESS ADDRESS: PLACE OF BIRTH: Passaic, New Jersey

530 First Avenue

New York, New York 10016 CITIZENSHIP: United States

BUSINESS TELEPHONE: 212-263-7416

EMAIL: [email protected]

EDUCATION AND TRAINING

UNDERGRADUATE:

1967 - 1971 Colgate University B.A. Biology major with honors

Hamilton, New York Magna Cum Laude, Austen Colgate Scholar

GRADUATE:

1971 -1975 New York University School of Medicine

New York, New York M.D.

POST GRADUATE:

7/75 - 6/76 Parkland Memorial Hospital PGY-1 in Obstetrics and Gynecology Program Director

Dallas, Texas Norman Gant,

M.D.

7/76 - 6/80 New York University Resident in Obstetrics and Gynecology Program Director

Affiliated Hospitals - Robert F. Porges, M.D.

Bellevue Hospital Center

New York, New York

APPOINTMENTS AND POSITIONS

ACADEMIC:

2

1980 -1981 Clinical Instructor (Ob-Gyn)

New York University School of Medicine

1981 -1988 Clinical Assistant Professor


1988 -1993 Assistant Professor of Obstetrics & Gynecology


1993 -1996 Associate Professor of Obstetrics & Gynecology (with tenure)


1996 - Professor of Obstetrics and Gynecology (with tenure)


NON-ACADEMIC POSITIONS:

1980 -1997 Founder and Advisor

Resident's Journal Club

Department of Obstetrics & Gynecology

School of Medicine


1993 - 1995 Director of Ultrasound

Women's Wellness Center

New York University Medical Center

1995 - Current Director of Gynecologic Ultrasound

Department of Obstetrics and Gynecology


1997 - Current Co-Director Bone Densitometry



2008 – Current Associate Director

Third Year Medical Student Clinical Clerkship

CERTIFICATION AND LICENSURE

1975 Diplomate

National Board of Medical Examiners

3

1976 New York State, License #127950

1981-2002 New Jersey, License #MA41162

SPECIALTY CERTIFICATION:

1983 American Board of Obstetrics and Gynecology

2001 Certified Menopause Clinician, North American Menopause Society

2001 Certified Clinical Densitometrist, International Society of Clinical Densitometry

2001 Certified American Society of Clinical Densitometrist

2003 Recertification, American Board of Obstetrics and Gynecology

2004 Recertification, American Society of Clinical Densitometrist







GRANTS AND RESEARCH:

Principal Site Investigator

Transvaginal Uterine Ultrasound and Hormone Replacement Therapy

Wyeth-Ayerst

Study 713 X 405-US

1993 -1994


Assessment of Effects on Early Postmenopausal Women

Eli Lilly

Study H35 MC GGHD

1995 - 1997

4


Chief Reporting Investigator for FDA Sign Off Raloxifene

Premarin and Placebo

Eli Lilly

Study H35 MC GGHG

1995 - 1997

Co-Investigator

The Helena Rubinstein Foundation

The Effect of Tamoxifen on the Reproductive System of Menopausal and Perimenopausal

Women with Breast Cancer

1995 - 1997

Co-Principal Site Investigator

STAR (Study of Tamoxifen And Raloxifene)

National Cancer Institution

1999 –2005


A Randomized Double-Blind, Multicenter, 24 week study to assess bleeding patterns in

postmenopausal women taking femhrt and Prempro

Pfizer

2002 - 2003


Phase III study of the efficacy and safety of lasofoxifene in the treatment of vaginal atrophy in

postmenopausal women

Pfizer

2003 - 2005

Principal Investigator

An 18-Month, Multicenter, Parallel-Group Study to Determine the Relative efficacy of

Risedronate Versus Raloxifene in Subjects Who Have Discontinued Hormone Replacement

Therapy (HRT) for Early Intervention in Osteoporosis.

Aventis

2004 - 2007

Subinvestigator

Study of Duloxetine HCl in Women of Different Demographic Characteristics and Co-

morbidities with Stress Urinary Incontinence: Evaluation of Efficacy and Safety.

Protocol F1J-US-SBCD

Eli Lilly

2004 -2005


5

A Prospective, Open-Label, Multi-Center, Two-Part Study to Investigate Patient

Satisfaction with Monthly Dosed Ibandronate Therapy in Women with Postmenopausal

Osteoporosis or Osteopenia Transitioned from Once-Weekly Alendronate or Risedronate.

Protocol # ML18056

Roche

2004 – 2006


A prospective, open-label, multicenter study to evaluate the change in bone turnover

markers after once monthly oral ibandronate therapy in treatment naïve postmenopausal

osteoporosis patients.

Protocol #ML18057

Roche

2005- 2006


“A Multcenter, Prospective, Observational study to determine the pattern of care and health

and economic outcomes associated with bone loss in postmenopausal women”

Protocol # 20040186-536

Amgen

2006


“DHEA against vaginal atrophy safety study of 12 months.

Protocol # ERC-230 Study

EndoCeutics, Inc. 2010


“Placebo-controlled, double-blind and randomized phase III study of 3-month intravaginalk

DHEA”

Protocol # ERC-231 Study

2010


“An open label study to evaluate the contraceptive efficacy and safety of norethindrone

acetate transdermal delivery system”

Protocol # NE0906

Watson

2011

Sub-Investigator

6

A randomized, parallel-group, double-blind, placebo-controlled, multi-center study to

assess the efficacy and safety of different doses of BAY 1002670 in subjects with uterine

fibroids.

Protocol 15788

Bayer

2014


A Randomized, Double-blind, Double-dummy, Parallel- Group, Multi-center Phase IIb

Study to Assess the Efficacy and Safety of Different Dose Combinations of an Aromatase

Inhibitor and a Progestin in an Intravaginal Ring Versus Placebo and Leuprorelin /

Leuprolide Acetate in Women with Symptomatic Endometriosis Over a 12-week

Treatment Period

Protocol 15832

Bayer

2014


A Muticenter, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and

Safety of a Single-Dose of COL-1077 in Women Undergoing Transvaginal Pipelle-

Directed Endometrial Biopsy

Protocol COL-1077

Juniper Pharmaceuticals, Inc.

2015


A Phase 3, Randomized, Double-blind, Placebo controlled Multicenter Study to Evaluate

the Efficacy and Safety of Ospemifene in Patients with Moderate to Severe Vaginal

Dryness, a Symptom of Vulvo-vaginal Atrophy (VVA) due to Menopause.

Protocol 1517I0231

Shionogi Inc.

2016


An International Phase 3 Randomized, Double-Blind, Placebo-Controlled Efficacy and

Safety Study to Evaluate Relugolix Administered with and without Low-Dose Estradiol

and Norethindrone Acetate in women with Endometriosis-Associated Pain.

Protocol MVT-601-3102

Myovant Sciences

2017


An International Phase 3 Double-Blind, Placebo-Controlled, Randomized Withdrawal

Study of Relugolix With Estradiol and Norethindrone Acetate in Women With Heavy

Menstrual Bleeding Associated With Uterine Fibroids

Protocol MVT-601-3002

7

Myovant Sciences

2018

Sub-Investigator

A Randomized, Doule-Blind, Placebo-Controlled, Phase 2 Trial Assessing the Efficacy,

Safety and Dose-Response of Quinagolide Extended-Release Vaginal Rings Administered

Sequentially for 8 Menstrual Cycles in Women with Moderate to Severe Endometriosis-

Related Pain.

Potocol 00165

Ferring Pharmaceuticals

2018

Princilal Investigator

Viveve Geneveve Treatment of the Vaginal Introitus to Evaluate Safety and Efficacy

Protocol VI-15-01

Viveve Inc.

2018


Effect of intravaginal Prasterone (DHEA) on Moderate to Severe Dyspareunia, a Symptom

of Vulvovaginal Atrophy Due to Menopause, In Women Under treatment with an

Aromatase Inhibitor for Breast Cancer – (Placebo-Controlled, Double-Blind and

Randomized.

Protocol ERC-260

EndoCeutics Inc.

2018


A Phase 3, Randomized, Placebo-controlled, 12-week Double-blind Study, Followed by a

Non-Controlled Extension Treatment Period, to Assess the Efficacy and Safety of

Fezolinetant in Women Suffering From Moderate to Severe Vasomotor Symptoms (Hot

Flashes) Associated With Menopause.

Protocol 2693-CL-0301/0302/0304

Astellas Pharma Global Development Inc.

2019


Incidence of the Ability to Successfully Image the Endometrial Echo on Transvaginal

Ultrasound in Asymptomatic Postmenopausal Women

Study s19-00307

NYU Langone Health

2019

8

OTHER RESEARCH RELATED ACTIVITIES:

1986 - Present Special Reviewer

International Journal of Obstetrics and Gynecology


American Journal of Obstetrics and Gynecology

1990 - 1998 Special Reviewer

Journal of Clinical Ultrasound


Fertility and Sterility


Journal of Ultrasound in Obstetrics and Gynecology

1993 - Present Editorial Board

Journal of Diagnostic Medical Sonographers

1994 -1998 Editorial Board

The Medical Tribune, Ob Gyn

1994 - 2008 Chairman

Scientific Paper Review: Gynecology

American Institute of Ultrasound in Medicine

Annual Meeting

1997 - Present Advisory Panel Member

Ultrasound Section of OBGYN.net


Journal of Clinical Ultrasound

1998 - Present American College of Ob/Gyn liaison to the American College Radiology

Women’s Health Imaging Panel

1998 - 2010 Editorial Board

OB-GYN Ultrasound Today

1998 - 2005 Board Examiner

American Board of Obstetrics and Gynecology

Oral Exams

1999 - 2001 American College of Ob/Gyn liaison member

of AHCPR funded Duke University Policy Center Study

9

Management of fibroids


Menopause, The

Journal of the North American Menopause Society

1999 - 2007 Editorial Board

Ultrasound in Obstetrics & Gynecology

2000 – Present Editorial Board

Journal of Ultrasound in Medicine

2000 – Present Editorial Board, Associate Editor

Journal of Ultrasound in Medicine

2003 – 2005 Editorial Advisory Board

Contemporary ObGyn


Menopausal Management

2004 – Present American Journal of Obstetrics and Gynecology

Subspecialty Area Editor – Gynecologic Ultrasound


Current Medical Imaging Reviews


OBG Managment


Climacteric

2008-Present Honorary Editorial Board

Clinical Medicine: Reproductive Health

HONORS

Phi Beta Kappa, Colgate University, 1970

Austen Colgate Scholar, 1971

10

Who's Who in American Colleges and Universities, 1971

Magna Cum Laude, Colgate University, 1971

Honors in Biology, Colgate University, 1971

Samuel Soffer Award - Outstanding Student in Urology

New York University Medical Center, 1975

Outstanding Paper in Obstetrics - 1988;

Contemporary Ob-Gyn

"New Insights Into Early Pregnancy"

1st Place Winner

"Best of the Best" 1995

Video Journal of Ob Gyn

"Use of Transvaginal Sonography in the Evaluation of Ectopic Pregnancy"

Award

The 13th Annual Rudy E. Sabbagha Lecture in Diagnostic Ultrasound

Northwestern University

Feinberg School of Medicine

“The continuing evolution in the ultrasound evaluation of the endometrium”

2010

Award

“2013 Royal College Visiting Professorship in Medical Research”

Royal College of Physicians and Surgeons of Canada

2013

Award

“2014 APGO Excellence in Teaching Award”

Associate of Professors of Gynecology and Obstetrics and the Department of

Obstetrics and Gynecology at NYU Langone Medical Center

2014

Award

Distinguished Alumnus Award

The Bellevue Obstetrical and Gynecological Society

2014

Elected Honorary Fellow, Royal College of Obstetricians and Gynecologists

(United Kingdom)

2014

Award

11

Alpha Omega Alpha

NYU School of Medicine

2015

Award

Thomas B. Clarkson Outstanding Clinical and Basic Science Research Award

North American Menopause Society

2016

Award

Joseph H. Holmes Clinical Pioneer Award


2019

MEMBERSHIPS IN PROFESSIONAL AND SCIENTIFIC SOCIETIES

1973 -1975 Committee on Admissions


1976 American College of Obstetrics and Gynecology

(Junior Fellow)

1977 – 1978 American College of Obstetrics and Gynecology

District II Junior Fellow Chairperson


Junior Fellow College Advisory Council

1978 American College of Obstetrics and Gynecology

Annual Clinical Meeting

Host Committee

1980 Bellevue Obstetrics and Gynecological Society

1980 – Present New York State Medical Society

1980 – Present New York County Medical Society

1980 – Present American Institute of Ultrasound in Medicine

1981 – Present American Society for Colposcopy and

Cervical Pathology

1983 – 2002 New York Perinatal Society

12

1983 – Present New York Gynecological Society

1984 – Present American College of Obstetrics and Gynecology (Fellow)

1984 – 1992 American Institute of Ultrasound in Medicine

(Senior Member)

1985 – 2000 American Society of Human Genetics

1985 – 1996 Gynecological Laser Society


Legislative Committee

1985 – 1987 Section on Ob-Gyn Ultrasound (American

Institute of Ultrasound in Medicine)

Executive Committee


Membership Committee

1986 – 1989 Tissue Review and Transfusion

Service Committee

Bellevue Hospital


Central Program Committee


Chairman, Membership Committee


CME Committee

1988 – 1989 Nominee, Board of Governors,


1988 – 1991 Board of Directors,

Vice Chairman

Friends of the Library


1988 – 1993 Corresponding Secretary


Alumni Association

13

1988 – 2000 Board of Directors,

American Registry of Diagnostic Medical

Sonographers

1990 – Present International Society of Ultrasound in Obstetrics & Gynecology


Media Committee


Ultrasound Practice Committee

1991 – 1994 American College of Obstetricians and Gynecologists

Vice Chairman New York Section, District II

1991 – 2009 Board of Directors, Chairman

Friends of the Library



(Fellow)

1993 – Present New York Obstetrical Society

1993 – Present North American Menopause Society


Ultrasound Practice Committee

Chairman

1993 – 1995 New York University

Independent Practice Association

Executive Committee

1993 – 2002 Vice President


Alumni Association

1994 – Present American Society of Reproductive Medicine


Secretary Treasurer

Section on Ob Gyn Ultrasound

1994 – 1997 American College of Obstetricians and Gynecologists

Chairman

14

New York Section, District II

1994 – 2005 American College of Radiology

Panel on Appropriateness Criteria – Women’s Imaging 1


Panel on Women’s Imaging Breast


Vice Chairman

Section on Ob Gyn Ultrasound

1995 – 1997 North American Menopause Society

Annual Meeting

Program Committee


Board of Governors


Chairman

Section on Ob/Gyn Ultrasound


Committee on Practice Bulletins - Gynecology


Finance Committee


Chairman

Education & Research Fund

2001– 2009 International Society of Ultrasound in Obstetrics & Gynecology

Program Committee

2001 – 2006 New York University School of Medicine

Department of Ob/Gyn

Faculty Council Representative

2002 – Present American Gynecologic and Obstetrical Society

Member


Board of Governors

15


Alumni Association

President Elect


Professional Education Committee

Chair Elect

2003 – 2009 Library Committee

New York University School of Medical


Gynecologic Practice Committee


Library Subcommittee for Strategic Planning, Chair


Liaison to ACR Women’s Health Imaging


First Vice President


Alumni Association

President


Professional Education Committee

Chair


Board of Trustees


Liaison to American College of Obstetrics and Gynecology, Gyn Practice

Committee


Treasurer


Treasurer

2009 – 2010 North American Menopausal Society

President Elect

16

2010 –2011 North American Menopausal Society

President

2010 – North American Menopause Society

Chair, Program Committee Annual Meeting


President Elect


President

2013 – 2015 President, American Institute of Ultrasound in Medicine

2014 – Present Board of Trustees, International Menopause Society


Committee on O-RADS

2015 – 2017 Past President, American Institute of Ultrasound in Medicine

2016 – 2018 Treasurer, International Menopause Society

2018 – 2020 President-Elect, International Menopause Society

2020 – Present President, International Menopause Society

PROFESSIONAL ACTIVITIES

TEACHING:

Founder and Faculty Advisor

Residents Journal Club

New York University-Bellevue Hospital Center

1979 – 1995

Liaison Physician Ob-Gyn Department to

Ultrasound Laboratory, Radiology Department,

Bellevue Hospital Center

1980 – 1993

Director of Ultrasound

Women's Wellness Center

17


1993 – 1995

Coordinator

Ob-Gyn Departmental Weekly Staff Conference

1987 – Present

Director of Gynecologic Ultrasound



1995 – Present

Co-Director, Bone Densitometry Unit



1997 – Present

Associate Director

Third Year Medical Student

Clinical Clerkship


2008 – Present

ACADEMIC INTERESTS:

Ultrasound in Gynecology, with special emphasis on endovaginal scanning, evolution of early

pregnancy failure, menopause, routine office use, saline infusion sonohysterography, abnormal

uterine bleeding, tamoxifen surveillance, three-dimensional scanning technology

Gender Specific Medicine

Selective Estrogen Receptor Modulation (SERM) for Postmenopausal Women’s Health

Clinical Management of Perimenopausal and Menopausal Women

Diagnosis, Prevention and Treatment of Osteoporosis

Female Sexual Dysfunction

Breast cancer chemoprevention

Prenatal genetic diagnosis in recurrent pregnancy loss

Postgraduate education

18

PUBLICATIONS

REFEREED ARTICLES:

Goldstein SR, Subramanyam BR, Raghavendra BN, et al. Subchorionic bleeding in threatened abortion:

sonographic findings and significance. AJR 141:975-979, 1983.

Subramanyam BR, Goldstein SR, Balthazar EJ, et al. Hematosalpinx in tubal pregnancy: sonographic-

pathologic correlation. AJR 141:361-364, 1983.

Coady DJ, Snyder JR, Subramanyam BR, Goldstein SR. Ultrasound diagnosis of interstitial pregnancy. NY

State J Med 85:655-657, 1985.

Goldstein SR, Snyder JR, Subramanyam BR. Crown rump length: gestational sac volume in early pregnancy.

J Reprod Med 31:320-325, 1986.

Goldstein SR, Subramanyam BR, Raghavendra BN, Horii S. Estimation of nongravid uterine volume. Obstet

Gynecol 72:86-90, 1988.

Goldstein SR, Snyder JR, Watson C. Combined sonographic-pathologic surveillance in elective first trimester

termination. Obstet Gynecol 71:747-750, 1988.

Goldstein SR, Snyder JR, Watson C. Detection of very early pregnancy in endovaginal sonography. Obstet

Gynecol 72:200-204, 1988.

Goldstein, SR; Subramanyam, B; Snyder, JR; Beller, U; Raghavendra, BN; Beckman, EM. The

postmenopausal cystic adnexal mass: The potential role of ultrasound in conservative management.

Obstetrical & gynecological survey. 44(5):391-392, 1989.

Goldstein SR, et al. Potential role of ultrasound in the conservative management of the postmenopausal cystic

adnexal mass. Obstet Gynecol 73:8-10 1989.

Rottem S, Thaler I, Goldstein SR, Timor-Tritsch IE, Brandes JM. Transvaginal sonographic technique:

targeted organ scanning without resorting to “planes”. J Clin Ultrasound. 1990;4:243-7.

Goldstein SR. Incorporating vaginal ultrasound into the overall gynecological examination. Am J Obstet

Gynecol 162:625-632, 1990.

Goldstein SR. Early detection of pathologic pregnancy by transvaginal sonography. J Clin Ultrasound 18:262-

273, 1990.

19

Goldstein SR, Nachtigall M, Snyder JR, Nachtigall L. Endometrial assessment by vaginal ultrasonography

before endometrial sampling in patients with postmenopausal bleeding. Am J Obstet Gynecol 163:119-123,

1990.

Goldstein SR. Embryonic ultrasonographic measurements: crown-rump length revisited. Am J Ob Gyn

165;3:497-501, 1991.

Goldstein SR. Significance of cardiac activity on endovaginal ultrasound in very early embryos. Obstet

Gynecol 80:670-2, 1992.

Goldstein SR. Conservative management of small postmenopausal cystic masses. Clin Obstet Gynecol.

1992;4:670-2.

Goldstein SR, Danon M, Watson C. An updated protocol for abortion surveillance with ultrasound and

immediate pathology. Obstet Gynecol 83:55-8, 1994.

Goldstein SR. Unusual ultrasound appearance of the uterus in patients receiving tamoxifen. Am J Obstet

Gynecol 170:447-451, 1994.

Goldstein SR. Use of ultrasonohysterography for triage of perimenopausal patients with unexplained uterine

bleeding. Am J Obstet Gynecol 170:565-570, 1994.

Goldstein SR. Postmenopausal endometrial fluid collections revisited: look at the doughnut rather than the

hole. Obstet Gynecol 83:738-40, 1994.

Goldstein SR, Wolfson R. Endovaginal ultrasonographic measurement of early embryonic size as a means of

assessing gestational age. J Ultrasound Med 13:27-31, 1994.

Goldstein SR. Embryonic death in early pregnancy: A new look at the first trimester. Obstet Gynecol

84:294-298, 1994.

Goldstein SR. Reprocessing of the vaginal probe between patients. Ultrasound Obstet Gynecol 7:4-5, 1996.

Goldstein SR. The routine use of ultrasound in the gynecological visit. Ultrasound Obstet Gynecol

1996;6:369-70.

Schwartz LB, Lazer S, Mark M, Nachtigall L. Horan C, Goldstein SR. Does the use of postmenopausal

hormone replacement therapy influence the size of uterine leiomyomata? A preliminary report. Menopause.

3:38-43, 1996.

Goldstein SR. Postmenopausal adnexal cysts: How clinical management has evolved. Am J Obstet Gynecol

175:1498-1501, 1996.

Goldstein SR, Kerenyi T, Scher J, Papp C. Correlation between karyotype and ultrasound in patients with

failed early pregnancy. Ultrasound In Obstet Gynecol 8:314-317;1996.

20

Schwartz LB, Krey L, Demopoulos R, Nachtigall LE, Goldstein SR, Mittal K. Alterations in steroid hormone

receptors in the Tamoxifen-treated endometrium. Am J Obstet Gynecol 176:129-137; 1997.

Goldstein SR, Zeltzer I, Horan CK, Snyder, Schwartz LB. Ultrasonography based triage for premenopausal

patients with abnormal uterine bleeding. Am J Obstetric Gynecology 1997;177:102-8.

Goldstein SR, Schwartz LB, Snyder JR, Horan C. Ultrasound based Endometrial Surveillance of the

Postmenopausal Patient on Tamoxifen. Journal of Gynecologic Techniques 1997;3:145-50.

Schwartz LB, Snyder J, Horan C, Porges RF, Nachtigall LE, Goldstein SR. The use of endovaginal

ultrasound and saline infusion sonohysterography for the evaluation of asymptomatic postmenopausal breast

cancer patients on tamoxifen. Ultrasound Obstet Gynecol 11:48-53, 1998.

Goldstein SR. Selective Estrogen Receptor Modulators: A New Category of Therapeutic Agents for

Extending the Health of Postmenopausal Women. Am J Obstet Gynecol 179:1479-84, 1998.

Schwartz LB, Rutkowski N, Horan C, Nachtigall LE, Snyder J, Goldstein SR Use of transvaginal

ultrasonography to monitor the effects of tamoxifen on uterine leiomyoma size and ovarian cyst formation.

Am J Obstet Gynecol 1998;179:1479-84.

Goldstein SR. Selective Estrogen Receptor Modulators: A New Category of compounds to extend

postmenopausal women’s health. Int J Fertil 1999;44:221-226

Goldstein SR, Scheele WH, Rajagopalan SK, Wilkie JL, Walsh BW, Parsons AK. A 12-month comparative

study of raloxifene, estrogen, and placebo on the postmenopausal endometrium. Obstet Gynecol. 2000; 95:95-

103.

Goldstein SR. Endometrial Histology of a novel HRT regimen. Int J Fertil March 2000;45:56-62

Goldstein SR, Siddhanti S, Ciaccia AV, Plouffe L Jr. A pharmacological review of selective oestrogen

receptor modulators. Hum Reprod Update 2000;6:212-24

Goldstein SR. Update on raloxifene to prevent endometrial-breast cancer. Eur J Cancer. 2000 Sep;36 Suppl

4:S54-6.

Bohm-Velez M, Mendelson E, Bree R, Finberg H, Fishman EK, Hricak H, Laing F, Sartoris D, Thurmond A,

Goldstein S. Ovarian cancer screening. American College Radiology. ACR Appropriateness Criteria.

Radiology 2000;215:S861-71.

Laing F, Mendelson E, Bohm-Velez M, Bree R, Finberg H, Fishman EK, Hricak H, Sartoris D, Thurmond A,

Goldstein S. First trimester bleeding. American College Radiology. ACR Appropriateness Criteria.

Radiology 2000;215:S879-93.

Thurmond A, Mendelson E, Bohm-Velez M, Bree R, Finberg H, Fishman EK, Hricak H, Laing F, Sartoris D,

Goldstein S. Role of imaging in second and third trimester bleeding American College Radiology. ACR

Appropriateness Criteria. Radiology 2000;215:S895-7.

21

Finberg H, Mendelson E, Bohm-Velez M, Bree R, Fishman EK, Hricak H, Laing F, Sartoris D, Thurmond A,

Goldstein S. Evaluation of multiple gestations. American College Radiology. ACR Appropriateness Criteria.

Radiology 2000;215:S903-14.

Finberg H, Mendelson E, Bohm-Velez M, Bree R, Fishman EK, Hricak H, Laing F, Sartoris D, Thurmond A,

Goldstein S. Growth disturbances: risk of intrauterine growth retardation. American College Radiology.

ACR Appropriateness Criteria. Radiology 2000;215:S914-24.

Bohm-Velez M, Mendelson E, Bree R, Finberg H, Fishman EK, Hricak H, Laing F, Sartoris D, Thurmond A,

Goldstein S. Suspected adnexal masses. American College Radiology. ACR Appropriateness Criteria.

Radiology 2000;215:S931-8.

Laing F, Mendelson E, Bohm-Velez M, Bree R, Finberg H, Fishman EK, Hricak H, Sartoris D, Thurmond A,

Goldstein S. Premature cervical dilatation. American College Radiology. ACR Appropriateness Criteria.

Radiology 2000;215:S939-45.

Goldstein SR, Neven P, Zhou L, Taylor YL, Ciaccia AV, Plouffe L. Raloxifene effect on frequency of

surgery for pelvic floor relaxation. Obstet Gynecol 2001;98:91-96

Goldstein SR, Monteagudo A, Popiolek D, Mayberry P, Timor-Trisch I. Evaluation of endometrial polyps.

Am J Obstet Gynecol 2002;20:669-674

Neven P, Goldstein SR, Ciaccia AV, Zhou Lifen, Silfen SL, Muram D. The effect of raloxifene on the

incidence of ovarian cancer in postmenopausal women. Gynecologic Oncol. 2002;85:388-390.

Goldstein SR, Nanavati N. Adverse events that are associated with the selective estrogen receptor modulator

levormeloxifene in an aborted phase III osteoporosis treatment study. Am J Obstet Gynecol 2002;187:521-

527.

Goldstein SR. An update on non-uterine gynaecological effects on raloxifene. European J of Cancer

2002;38:S65-66.

Goldstein SR. Routine use of office gynecologic ultrasound. J Ultrasound Med. 2002;21:489-92

Goldstein SR. Controversy about uterine effects and safety of SERMs: the saga continues. Menopause.

2002;9:381-4.

Timor-Tritsch I, Monteagudo A, Rebarber A, Goldstein SR, Tsymbal R. Transrectal scanning: an alternative

when transvaginal scanning is not feasible. Ultrasound Obstet Gynecol 2003;21:473-479.

Timor-Tritsch IE, Masch RJ, Goldstein SR, Ng E, Monteagudo A. Transvaginal ultrasound-assisted

gynecologic surgery: evaluation of a new device to improve safety of intrauterine surgery. Am J Obstet

Gynecol. 2003;189:1074-9.

22

Goldstein SR. Reducing the risk of breast cancer: key trials and their impact on practice. OBG Management

2003;15:39-48.

Breitkopf D, Goldstein SR, Seeds JW; ACOG Committee on gynecologic Practice. ACOG technology

assessment in obstetrics and gynecology. Number 3, September 2003. Saline Infusion Sonohysterography.

Obstet Gynecol. 2003;102:659-62

Goldstein SR. The endometrial echo revisted: Have we created a monster? Am J Ob Gyn

2004;191:1092-1096.

Goldstein SR. How do we choose candidates for breast cancer prevention? European Journal of Cancer.

Supplement 2004;2:26-28.

Goldstein SR. The case for less-than-monthly progestogen in women on HT: is transvaginal ultrasound

the key? Menopause. 2005;12:110-13.

Timor-Tritsch IE. Goldstein SR. The complexity of a “complex mass” and the simplicity of the “simple

cyst”. J Ultrasound Med. 2005;24:255-58

Goldstein SR, Johnson S, Watts NB, Ciaccia AV, Elmerick D, Muram D. Incidence of urinary

incontinence in postmenopausal women treated with raloxifene or estrogen. Menopause. 2005;12:1-5.

Goldstein SR. Osteopenia: Sorting out the confusion. Menopause Management 2006;15:00-17.

Goldstein SR. Abnormal Uterine Bleeding: The role of Ultrasound. Ultrasound Clinics. 2006;1:415-

424.

Condous G, Timmerman D, Goldstein SR, Valentin L, Jurkovic D, Bourne T. Pregnancies of unknown

location: consensus statement. Ultrasound Obstet Gynecol. 2006;28:121-2.

Goldstein SR. Not all SERMs are created equal. Menopause. 2006;13:325-7.

Goldstein SR. Raloxifene vs. tamoxifen. JAMA. 2007;297:263-4.

Goldstein SR. Accreditation, certification: why all the confusion? Obstet Gynecol. 2007;110:1396-8.

Goldstein SR. Predicting uterine weight before hysterectomy: ultrasound measurements vs. clinical

assessment. Am J Obstet Gynecol. 2007;196:e16.

Birkhauser MH, Panay N, Archer DF, Barlow D, Burger H, Gambacciani M, Goldstein S, Pinkerton JA,

Sturdee DW. Updated practical recommendations for hormone replacement therapy in the peri-and

postmenopause. Climacteric 2008;11:108-123.

Utian WH, Archer DF, Bachmann GA, Gallagher C, Grodstein Fn, Heiman JR, Henderson VW, Hodis

HN, Karas RH, Lobo RA, Manson JE, Reid RL, Schmidt PJ, Stuenkel CA; North American Menopause

Society. Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The

23

North American Menopause Society. Menopause. 2008;15:584-602.

Goldstein SR. Ultrasound scanning in reproductive medicine and infertility. Preface. Semin Reprod Med.

2008;26:215.

Stojadinovic A, Nissan A, Shriver CD, Mittendorf EA, Akin MD, Dickerson V, Lenington S, Platt LD,

Stavros T, Goldstein SR, Moskovitz O, Gallimidi Z, Fields SI, Yeshaya A, Allweis TM, Manassa R,

Pappo I, Ginor RX, D'Agostino RB, Gur D Electrical impedance scanning as a new breast cancer risk

stratification tool for young women. J Surg Oncol. 2008;97:112-20.

Goldstein SR. The role of transvaginal ultrasound or endometrial biopsy in the evaluation of the

menopausal endometrium. Am J Obstet Gynecol. Am J Obstet Gynecol. 2009;201:5-11.

Cummings SR, Ensrud K, Delmas PD, LaCroix AZ, Vukicevic S, Reid DM, Goldstein S, Sriram U, Lee

A, Thompson J, Armstrong RA, Thompson DD, Powles T, Zanchetta J, Kendler D, Neven P, Eastell R;

PEARL Study Investigators. Lasofoxifene in postmenopausal women with osteoporosis. N Engl J Med.

2010;362:686-96.

Leone FP, Timmerman D, Bourne T, Valentin L, Epstein E, Goldstein SR, Marret H, Parson AK, Gull B,

Istre O, Sepulveda W, Ferrazzi E, Van den Bosch T. Terms, definitions, and measurements to describe the

sonographic features of the endometrium and intrauterine lesions: a consensus opinion from the

International Endometrial Tumor analysis (IETA) group. Ultrasound Obstet Gynecol. 2010;35:103-12.

Pinkerton JV, Goldstein SR. Endometrial safety: A key hurdle for selective estrogen receptor modulators

in development. Menopause. 2010; 17:642-53

Goldstein SR, Neven P, Cummings S, Colgan T, Runowicz CD, Krpan D, Proulx J, Johnson M,

Thompson D, Thompson J, Sriram U. Postmenopausal evaluation and risk reduction with lasofoxifene

trial: 5-year gynecological outcomes. Menopause. 2010 Aug 3.

Goldstein SR. Modern evaluation of the endometrium. Obstet Gynecol. 2010;116:168-76

Goldstein SR. Selective estrogen receptor modulator: the saga continues. Menopause. 2010;17:231-2.

Barnhart KT, van Mello N, Bourne T, Kirke E, Van Calster B, Bottomley C, Chung K, Condous G,

Goldstein SR, Hajenius P, Mol BW, Molinaro T, O’Flynn O’Brien K, Husicka R, Sammel M,

Timmerman D. Pregnancy of unknown location: A consensus statement of nomenclature, definitions,

and outcome. Fertilityand Sterility. 2011;95:857-66.

Goldstein SR. Significance of incidentally thick endometrial echo on transvaginal ultrasound in

postmenopausal women. Menopause 2011;18:434-436.

Goldstein SR. Introduction to a special section on the causality, diagnosis, and management of abnormal

uterine bleeding. Menopause. 2011;18:406-407.

Golstein SR. The proper use of ultrasound in gynecologic practice. ACOG UPDATE 2011;36.

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Stojadinovic%20A%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlushttp://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Nissan%20A%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlushttp://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Shriver%20CD%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlushttp://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Mittendorf%20EA%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlushttp://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Akin%20MD%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlushttp://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Dickerson%20V%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlushttp://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Lenington%20S%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlushttp://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Platt%20LD%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlushttp://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Stavros%20T%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlushttp://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Goldstein%20SR%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlushttp://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Moskovitz%20O%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlushttp://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Gallimidi%20Z%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlushttp://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Fields%20SI%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlushttp://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Yeshaya%20A%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlushttp://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Allweis%20TM%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlushttp://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Manassa%20R%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlushttp://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Pappo%20I%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlushttp://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Ginor%20RX%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlushttp://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22D'Agostino%20RB%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlushttp://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Gur%20D%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus

24

Goldstein SR, Bhattoa HP, Neven P, Cox DA, Dowsett SA, Alam J, Sipos A, Muram D. Gynecologic

effects of arzoxifene in postmenopausal women with osteoporosis or low bone mass. Menopause.

2012;19:41-7.

Goldstein SR. Bone health medications: research questions versus clinical choices. Menopause.

2012;19:41-7.

Goldstein SR. Sonohysterography in postmenopausal bleeding. J Ultrasound Med. 2012;31:333-336.

Goldstein SR. Gynecologic effects of Arzoxifene in postmenopausal women with osteoporosis or low

bone mass. Menopause. 2012;19:41-7.

Goldstein SR. The sound judgement series. J Ultrasound Med. 2012;31:189-90.

North American Menopause Society. The 2012 hormone therapy position statement of: The North

American Menopause Society. Menopause. 2012;19:257-71.

Tsai MC, Goldstein SR. Office diagnosis and management of abnormal uterine bleeding. Clin Obstet

Gynecol. 2012;55:635-50

Bourne T, Barnhart K, Benson CB, Brosens J, Van Calster B, Condous G, Coomerasamy A, Doubilet PM,

Goldstein SR, Gould D, Kirk E, Mol BW, Raine-Fenning N, Stalder C, Timmerman D. NICE guidance

on ectopic pregnancy and miscarriage restricts access and choice and may be clinically unsafe. BMJ.

2013; 346:f197.

Sakhel K, Benson CB, Platt LD, Goldstein SR, Benacerraf BR.Begin With the Basics: Role of 3-

Dimensional Sonography as a First-line Imaging Technique in the Cost-effective Evaluation of

Gynecologic Pelvic Disease. J Ultrasound Med. 2013;32:381-8.

Goldstein, SR. Postmenopausal dyspareunia: has the Food and Drug Administration really helped?

Menopause. 2013;20:596-7.

Doubilet PM, Benson CB, Bourne T, Blaivas M; Society of Radiologists in Ultrasound Multispecialty

Panel on Early First Trimester Diagnosis of Miscarriage and Exclusion of a Viable Intrauterine Pregnancy,

Barnhart KT, Benacerraf BR, Brown DL, Filly RA, Fox JC, Goldstein SR, Kendall JL, Lyons EA, Porter

MB, Pretorius DH, Timor-Tritsch IE. Diagnostic criteria for nonviable pregnancy early in the first

trimester. N Engl J Med. 2013;369:1443-51.

Nachtigall MJ, Nazem TG, Nachtigall RH, Goldstein SR. Osteoporosis risk factors and early life-style

modifications to decrease disease burden in women. Clin Obstet Gynecol. 2013;56:650-3.

Goldstein, SR. Still another selective estrogen receptor modulator to enhance women’s health: this time in

combination with conjugated equine estrogens. Menopause. 2014;21:1-2.

Goldstein SR, Bachmann GA, Koninckx PR, Lin VH, Portman DJ, Ylikorkala O; Ospemifene Study

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Goldstein%20SR%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Bhattoa%20HP%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Neven%20P%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Cox%20DA%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Dowsett%20SA%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Alam%20J%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Sipos%20A%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Muram%20D%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=21993078http://www.ncbi.nlm.nih.gov/pubmed/22828096http://www.ncbi.nlm.nih.gov/pubmed?term=Bourne%20T%5BAuthor%5D&cauthor=true&cauthor_uid=23341557http://www.ncbi.nlm.nih.gov/pubmed?term=Barnhart%20K%5BAuthor%5D&cauthor=true&cauthor_uid=23341557http://www.ncbi.nlm.nih.gov/pubmed?term=Benson%20CB%5BAuthor%5D&cauthor=true&cauthor_uid=23341557http://www.ncbi.nlm.nih.gov/pubmed?term=Brosens%20J%5BAuthor%5D&cauthor=true&cauthor_uid=23341557http://www.ncbi.nlm.nih.gov/pubmed?term=Van%20Calster%20B%5BAuthor%5D&cauthor=true&cauthor_uid=23341557http://www.ncbi.nlm.nih.gov/pubmed?term=Condous%20G%5BAuthor%5D&cauthor=true&cauthor_uid=23341557http://www.ncbi.nlm.nih.gov/pubmed?term=Coomerasamy%20A%5BAuthor%5D&cauthor=true&cauthor_uid=23341557http://www.ncbi.nlm.nih.gov/pubmed?term=Doubilet%20PM%5BAuthor%5D&cauthor=true&cauthor_uid=23341557http://www.ncbi.nlm.nih.gov/pubmed?term=Goldstein%20SR%5BAuthor%5D&cauthor=true&cauthor_uid=23341557http://www.ncbi.nlm.nih.gov/pubmed?term=Gould%20D%5BAuthor%5D&cauthor=true&cauthor_uid=23341557http://www.ncbi.nlm.nih.gov/pubmed?term=Kirk%20E%5BAuthor%5D&cauthor=true&cauthor_uid=23341557http://www.ncbi.nlm.nih.gov/pubmed?term=Mol%20BW%5BAuthor%5D&cauthor=true&cauthor_uid=23341557http://www.ncbi.nlm.nih.gov/pubmed?term=Raine-Fenning%20N%5BAuthor%5D&cauthor=true&cauthor_uid=23341557http://www.ncbi.nlm.nih.gov/pubmed?term=Stalder%20C%5BAuthor%5D&cauthor=true&cauthor_uid=23341557http://www.ncbi.nlm.nih.gov/pubmed?term=Timmerman%20D%5BAuthor%5D&cauthor=true&cauthor_uid=23341557http://www.ncbi.nlm.nih.gov/pubmed/?term=23341557http://www.ncbi.nlm.nih.gov/pubmed?term=Sakhel%20K%5BAuthor%5D&cauthor=true&cauthor_uid=23443177http://www.ncbi.nlm.nih.gov/pubmed?term=Benson%20CB%5BAuthor%5D&cauthor=true&cauthor_uid=23443177http://www.ncbi.nlm.nih.gov/pubmed?term=Platt%20LD%5BAuthor%5D&cauthor=true&cauthor_uid=23443177http://www.ncbi.nlm.nih.gov/pubmed?term=Goldstein%20SR%5BAuthor%5D&cauthor=true&cauthor_uid=23443177http://www.ncbi.nlm.nih.gov/pubmed?term=Benacerraf%20BR%5BAuthor%5D&cauthor=true&cauthor_uid=23443177http://www.ncbi.nlm.nih.gov/pubmed/?term=23443177

25

Group. Ospemifene 12-month safety and efficacy in postmenopausal women with vulvar and vaginal

atrophy. Climacteric. 2014;17:173-82.

Manson JE, Goldstein SR, Kagan R, Kaunitz AM, Liu JH, Pinkerton JV, Rebar RW, Scnatz PF, Shifren

JL, Stuenkel CA, Gass MLS, Utian WH. Why the product labeling for low-dose vaginal estrogen should

be changed. Menopause. 2014;21:911-916.

American Institute of Ultrasound in Medicine (AIUM); American College of Radiology (ACR); American

College of Obstetricians and Gynecologists (ACOG); Society for Pediatric Radiology (SPR); Society of

Radiologists in Ultrasound (SRU). AIUM practice guideline for the performance of ultrasound of the

female pelvis. J Ultrasound Med. 2014;33:1122-30.

Goldstein SR, Timor-Tritch IE, Monteagudo A, Monda S, Popiolek D. Cystadenofibromas: Can

transvaginal ultrasound appearance reduce some surgical interventions? J Clin Ultrasound. 2014;0:1-4

Goldstein SR. Ovarian conservation at the time of hysterectomy for benign disease: Where is the

pendulum now? Climacteric. 2014;17:721-2.

Goldstein SR. Update on Osteoporosis. OBG Management . 2014;26:40-5.

Constantine GD, Goldstein SR, Archer DF. Endometrial safety of ospemifene: Result of the phase 2/3

clinical development program. Menopause. 2015;22:36-43.

Manson JE, Ames JM, Shapiro M, Gass ML, Shifren JL, Stuenkel CA, Pinkerton JV, Kaunitz AM, Pace

DT, Kagan R, Schnatz PF, Kingsberg SA, Liu JH, Joffe H, Richard-Davis G, Goldstein SR, Schiff I, Utian

WH. Algorithm and mobile app for menopausal symptom management and hormonal/non-hormonal

therapy decision making: a clinical decision-support tool from The North American Menopause Society.

Menopause. 2015; 22:247-53.

Benacerraf BR, Abuhamad AZ, Bromley B; Goldstein SR, Groszmann Y, Shipp TD, Timor-Tritsch, IE.

Consider ultrasound first for imaging the female pelvis. American journal of obstetrics & gynecology.

2015; 212(4):450-455.

Van Den Bosch T, Dueholm M., Leone FPG, Valentin L, Rassmussen CK, Votino A, Van Schouboeck,

Landolfo C, Installe AJF, Guerriero S, Exacoustos C, Gordts S, Benacerraf B, D’Hooghe T, De Moor B,

Brölmann H, Goldstein S, Epstein E, Bourne T, Timmerman D. Terms, definitions and measurements to

describe sonographic features of myometrium and uterine masses: a consensus opinion from the

Morphological Uterus Sonographic Assessment (MUSA) group. Ultrasound in Obstetrics and

Gynecology. 2015;46

Goldstein SR, Espié M, Druckmann R. Does purified Swedish pollen extract, a nonhormonal treatment for

vasomotor symptoms, inhibit the CYP2D enzyme system? Menopause 2015: 22; 1212-1214.

Goldstein SR. Update on Osteoporosis. OBG Management 2015;27:31-39.

Goldstein SR, Carroll RC. It’s time to rethink atypical glandular cells on pap smear. Contemp OB/GYN

2015;60:28-32.

26

Kagan R, Goldstein SR, Pickar JH, Komm BS. Patient considerations in the management of menopausal

symptoms: role of conjugated estrogens with bazedoxifene. Ther Clin Risk Manag 2016;12:549-62

Goldstein SR. Update on Bone Health. OBG Management 2016;28:34-40.

Glanc P, Benacerraf B, Bourne T, Brown D, Coleman BG, Crum C, Dodge J, Levine D, Pavlik E,

Timmerman D, Ueland FR, Wolfman W, Goldstein SR. First International Consensus Report on Adnexal

Masses: Management Recommendations. J Ultrasound Med 2017;36:849-63.

Goldstein SR. Transcutaneous Nerve Stimulation for Pain Relief During Office Hysteroscopy: A

Randomized Controlled Trial. Obstet Gynecol 2017;129:1141.

Wheeler KC, Goldstein SR. Transvaginal ultrasound for the diagnosis of abnormal uterine bleeding. Clin

Obstet Gynecol 2017;60(1):11-17.

Goldstein SR, Lumsden MA. Abnormal uterine bleeding in perimenopause. Climacteric 2017;20:414-420.

Goldstein SR. Update on Bone Health. OBG Management 2017;29-32.

Taylor HS, Adamson GD, Diamond MP, Goldstein SR, Horne AW, Missmer SA, Snabes MC, Surrey E,

Taylor RN. An evidence-based approach to assessing surgical versus clinical diagnosis of symptomatic

endometriosis. Int J Gynaecol Obstet. 2018;142:131-142.

Andreotti RF, Timmerman D, Benacerraf BR; Bennett GL, Bourne T, Brown DL, Coleman BG; Frates

MC, Froyman W, Goldstein SR, Hamper UM, Horrow MM, Hernanz-Schulman M, Reinhold C,

Strachowski LM, Glanc P. Ovarian-Adnexal Reporting Lexicon for Ultrasound: A White Paper of the

ACR Ovarian-Adnexal Reporting and Data System Committee. J Am Coll Radiol. 2018;15:1415-1429.

Goldstein SR. Ultrasound in menopause: a look back. Menopause 2018;25:145-148.

Goldstein SR. Appropriate evaluation of postmenopausal bleeding. Menopause 2018; Sep 17. doi:

10.1097/GME.0000000000001181. [Epub ahead of print]

Portman DJ, Goldstein SR, Kagan R. Treatment of moderate to severe dyspareunia with intravaginal

prasterone therapy: a review. Climacteric 2018; December 17:1-8. doi:

10.1080/13697137.2018.1535583. [Epub ahead of print]


Goldstein SR. NAMS Practice Pearl: Appropriate evaluation of postmenopausal bleeding. Menopause

2018;25:1476-1478.

https://www.ncbi.nlm.nih.gov/pubmed/?term=Glanc%20P%5BAuthor%5D&cauthor=true&cauthor_uid=28266033https://www.ncbi.nlm.nih.gov/pubmed/?term=Benacerraf%20B%5BAuthor%5D&cauthor=true&cauthor_uid=28266033https://www.ncbi.nlm.nih.gov/pubmed/?term=Bourne%20T%5BAuthor%5D&cauthor=true&cauthor_uid=28266033https://www.ncbi.nlm.nih.gov/pubmed/?term=Brown%20D%5BAuthor%5D&cauthor=true&cauthor_uid=28266033https://www.ncbi.nlm.nih.gov/pubmed/?term=Coleman%20BG%5BAuthor%5D&cauthor=true&cauthor_uid=28266033https://www.ncbi.nlm.nih.gov/pubmed/?term=Crum%20C%5BAuthor%5D&cauthor=true&cauthor_uid=28266033https://www.ncbi.nlm.nih.gov/pubmed/?term=Dodge%20J%5BAuthor%5D&cauthor=true&cauthor_uid=28266033https://www.ncbi.nlm.nih.gov/pubmed/?term=Levine%20D%5BAuthor%5D&cauthor=true&cauthor_uid=28266033https://www.ncbi.nlm.nih.gov/pubmed/?term=Pavlik%20E%5BAuthor%5D&cauthor=true&cauthor_uid=28266033https://www.ncbi.nlm.nih.gov/pubmed/?term=Timmerman%20D%5BAuthor%5D&cauthor=true&cauthor_uid=28266033https://www.ncbi.nlm.nih.gov/pubmed/?term=Ueland%20FR%5BAuthor%5D&cauthor=true&cauthor_uid=28266033https://www.ncbi.nlm.nih.gov/pubmed/?term=Wolfman%20W%5BAuthor%5D&cauthor=true&cauthor_uid=28266033https://www.ncbi.nlm.nih.gov/pubmed/?term=Goldstein%20SR%5BAuthor%5D&cauthor=true&cauthor_uid=28266033https://www.ncbi.nlm.nih.gov/pubmed/28538485https://www.ncbi.nlm.nih.gov/pubmed/28538485https://www.ncbi.nlm.nih.gov/pubmed/?term=Taylor%20HS%5BAuthor%5D&cauthor=true&cauthor_uid=29729099https://www.ncbi.nlm.nih.gov/pubmed/?term=Adamson%20GD%5BAuthor%5D&cauthor=true&cauthor_uid=29729099https://www.ncbi.nlm.nih.gov/pubmed/?term=Diamond%20MP%5BAuthor%5D&cauthor=true&cauthor_uid=29729099https://www.ncbi.nlm.nih.gov/pubmed/?term=Goldstein%20SR%5BAuthor%5D&cauthor=true&cauthor_uid=29729099https://www.ncbi.nlm.nih.gov/pubmed/?term=Horne%20AW%5BAuthor%5D&cauthor=true&cauthor_uid=29729099https://www.ncbi.nlm.nih.gov/pubmed/?term=Missmer%20SA%5BAuthor%5D&cauthor=true&cauthor_uid=29729099https://www.ncbi.nlm.nih.gov/pubmed/?term=Snabes%20MC%5BAuthor%5D&cauthor=true&cauthor_uid=29729099https://www.ncbi.nlm.nih.gov/pubmed/?term=Surrey%20E%5BAuthor%5D&cauthor=true&cauthor_uid=29729099https://www.ncbi.nlm.nih.gov/pubmed/?term=Taylor%20RN%5BAuthor%5D&cauthor=true&cauthor_uid=29729099

27

Constantine GD, Kessler G, Graham S, Goldstein SR. Increased incidence of endometrial cancer

following the women's health initiative: An assessment of risk factors. Journal of Women's

Health 2019;28:237-243.

Portman, D.J., Goldstein, S.R., Kagan, R. Treatment of moderate to severe dyspareunia with intravaginal

prasterone therapy: a review. Climacteric 2019;22:65-72.

Archer DF, Goldstein SR, Simon JA, Waldbaum AS, Sussman SA, Altomare C, Zhu J, Yoshida Y,

Schaffer S, Soulban G. Efficacy and safety of ospemifene in postmenopausal women with moderate-to-

severe vaginal dryness: a phase 3, randomized, double-blind, placebo-controlled, multicenter trial.

Menopause 2019;26;611-21.

Khafaga A, Goldstein SR. Abnormal uterine bleeding. Obstetrics & gynecology clinics of North America.

2019;46:595-605. DOI: 10.1016/j.ogc.2019.07.001.

Archer DF, Simon JA, Portman DJ, Goldstein SR, Goldstein I. Ospemifene for the treatment of

menopausal vaginal dryness, a symptom of the genitourinary syndrome of menopause. Expert Review of

Endocrinology & Metabolism. 2019;14:301-314.

Esposito DB, Banerjee G, Yin R,

Russo L,

Goldstein S,

Patsner B,

Lanes S. Development and Validation

of an Algorithm to Identify Endometrial Adenocarcinoma in US Administrative Claims Data. Journal of

Cancer Epidemiology; 2019, https://doi.org/10.1155/2019/1938952.

Andreotti RF, Timmerman D, Strachowski LM, Froyman W, Benacerraf BR, Bennett GL, Bourne T,

Brown DL, Coleman BG, Frates MC, Goldstein SR, Hamper UM, Horrow MM, Hernanz-Schulman M,

Reinhold C, Rose SL, Whitcomb BP, Wolfman WL, Glanc P. O-RADS US Risk Stratification and

Management System: A Consensus Guideline from the ACR Ovarian-Adnexal Reporting and Data

System Committee. Radiology; 2019 (Nov 5):191150.

Esposito DB, Banerjee G, Yin R, Russo L, del Carmen MG, Goldstein S, Patsner B, Lanes S.

Development and Validation of an Algorithm to Identify Endometrial Adenocarcinoma in US

Administrative Claims data. Journal of Cancer Epidemiology; 2019, doi: 10.1155/2019/1938952.


Genazzani A, Panay N, Simoncini T, Depypere H, Mueck A, Egarter C, Biglia N, Fait T, Birkhaeuser M,

Skouby SO, Brincat M, Goldstein S, Ruan X, Celis-Gonzales C, Palacios S. Purified and Specific

Cytoplasmic Pollen Extract: A Non-hormonal Alternative for the Treatment of Menopausal Symptoms.

Gynecol Endocrinol; 2020, https://doi.org/10.1080/09513590.2020.1722994.

Mirkin S, Goldstein SR, Archer DF, Pickar JH, Graham S, Bernick B.

Endometrial Safety and Bleeding Profile of a 17β-estradiol/progesterone Oral Softgel Capsule (TX-

001HR). Menopause; 2020 doi: 10.1097/GME.0000000000001480.

28

Mathew Leonardi, Kristy P Robledo, Steven R Goldstein, Beryl R Benacerraf, George Condous.

International Survey Finds Majority of Gynecologists Are Not Aware of and Do Not Utilize Ultrasound

Techniques to Diagnose and Map Endometriosis. Ultrasound Obstet Gynecol; 2020 doi:

10.1002/uog.21996. Online ahead of print.

J. H. Pickar, D. F. Archer, S. R. Goldstein, R. Kagan, B. Bernick & S. Mirkin (2020) Uterine bleeding

with hormone therapies in menopausal women: a systematic review. Climacteric;

2020 doi: 10.1080/13697137.2020.1806816. Online ahead of print.

REVIEWS, BOOKS AND BOOK CHAPTERS, INVITED PAPERS:

Goldstein SR. Endovaginal Ultrasound Alan R. Liss Co., New York 1988.

Goldstein SR, Woletz P. Diagnostic Medical Sonography Volume II: Obstetrics and Gynecology.

Fertilization and Embryology; Chapter 12. Kawamura, Berman, Craig, ed. Lippincott, New York 1991.

Woletz P, Goldstein SR. Diagnostic Medical Sonography Volume II: Obstetrics and Gynecology. Abnormal

first trimester pregnancy; Chapter 20. Kawamura, Berman, Craig, ed. Lippincott, New York 1991.

Goldstein SR. Endovaginal Ultrasound 2nd Ed; Wiley Liss, New York, 1991.

Goldstein SR. The Postmenopause and the use of ultrasound. Clinics in Infertility and Reproductive

Medicine 2:715, 1991.

Goldstein SR: Use of endovaginal ultrasound in the overall gynecologic examination. Obstet Gynecol Clin

North Am 18:779, 1991.

Goldstein SR. Pregnancy: Early landmarks in the normal & abnormal Clinics in Infertility and Reproductive

Medicine 2:699, 1991.

Goldstein SR, Snyder JR. Method of gynecologic ultrasound examination. Chapter in Textbook of

Ultrasound in Obstetrics and Gynecology (Editors: Chervenak FA, Issacson G, Campbell S.) Little Brown &

Co., p.221-228, 1993.

Goldstein SR. Vaginal ultrasound evaluation of the early fetus. Chapter in The High Risk Fetus (Editors:

Lin Chin C, Verp MS, Sabbagha RE.) Springer-Verlag p.146-159 1993.

Goldstein SR. Office Ultrasound of the Pelvis in Office Gynecology Advanced Management Concepts

(Editors: Knaus JV, Issacs JH) Springer-Verlag p.121-134 1993.

Goldstein SR. Conservative Management of Small Postmenopausal Cystic Masses in Clin Obstet Gynecol

36:395-401, 1993.

https://doi.org/10.1080/13697137.2020.1806816

29

Goldstein SR. Sonography in early pregnancy failure. Clin Obstet Gynecol 37:681-92, 1994.

Goldstein SR. Transvaginal Ultrasonography and The Postmenopausal Woman. Infertility and Transvaginal

Sonography Current Concepts. (Editors: Desai S, Allahbadia G) Jaypee Brothers Medical Publishers. 1995.

Goldstein SR. Vaginal ultrasound as an aid in the diagnosis of gynecological problems. Focus & Opinion:

Obstetrics and Gynecology 1:249-261, July 1995. (Editors: Mishell D, Herbst A, Kirschbaum T.) Mosby-

Year Book Inc.

Goldstein SR, Timor-Tritsch IE. Ultrasound in Gynecology. Churchill Livingstone Inc. 1995.

Parsons AK, Cullinan J, Goldstein SR, Fleischer A. Sonohysterography, sonosalpingography,

sonohysterosalpingography: A text atlas of normal and abnormal findings. Sonography in Obstetrics and

Gynecology: Principles and Practice: Fifth Edition. (Editor: Fleischer A.) Appleton & Lange Fifth Edition

1995.

Goldstein SR. Office Use of Endovaginal Ultrasound. Women's Primary Health Care: Office Practice and

Procedures. (Editors: Seltzer V, Pearse W) McGraw-Hill, 1995.

Goldstein SR. Saline infusion sonohysterography. Office Ultrasound for the Practicing Gynecologist.

Clinical Obstetrics and Gynecology 39:248-258, 1996.

Goldstein SR. Vaginal Ultrasound as an aid in the diagnosis of gynecological problems. Current Problems in

Obstetrics, Gynecology and Fertility 19:227-40, 1996.

Goldstein SR, Schwartz LB. Evaluation of abnormal vaginal bleeding in perimenopausal women with

endovaginal ultrasound and saline infusion sonohysterography. Ann N Y Acad Sci. 1997;828:208-12

Goldstein SR, McClung MR. Potential Impact of Emerging Therapies on Osteoporosis Prevention. Am J

Managed Care 4:S78, 1998.

Goldstein SR. Effect of SERM's on Breast Tissue. J Endocrin Invest. 22:636-640,1999.

Steven R. Goldstein, MD, Francis R. M. Jacot, MD, CM, CCFP, Claude Poulin, MD, & D. Scott Poehlmann,

MD, Documenting Pregnancy and Gestational Age, in A Clinician’s Guide to Medical and Surgical Abortion

39–51 (Maureen Paul, MD, MPH, et al. eds. 1999).

Goldstein SR. Endometrial Histology of a Novel HRT Regimen. Int J Fertil 45:81-86, 2000

Goldstein SR. Drugs for the Gynecologist to Prevent Breast Cancer: Current Status, Future Trends. Am J

Obstet Gynecol 2000;185:1121-6. Review.

Goldstein RB, Bree RL, Benson CB, Benacerraf BR, Bloss JD, Carlos R, Fleischer AC, Goldstein SR, Hunt

RB, Kurman RJ, Kurtz AB, Laing FC, Parsons AK, Smith-Bindman R, Walker J. Evaluation of the woman

with postmenopausal bleeding: Society of Radiologists in Ultrasound-Sponsored Consensus Conference

statement. J Ultrasound Med. 2001;20:1025-36. Review.

30

Goldstein SR, Benson CB. Imaging of the Infertile Couple. Martin Dunitz, 2001

Goldstein SR. The effect of SERMs on the Endometrium. Chapter in Selective Estrogen Receptor modulators

(SERMs) (Editors: Marietta A, Dunn BK, Sherman S) Annals of the New York Academy of Sciences,

Volume 949, p237-242, 2001

Goldstein SR. The effect of SERMs on the Endometrium. Ann N Y Acad Sci. 2001;949:237-42. Review.

Goldstein SR, The effects of Selective Estrogen Receptor Modulators on the endometrium. Chapter in

Hormone Replacement Therapy and Cancer. The current studies of research and practice. Editor A.R.

Genazaani. Pathenon Publishing 2002, London.

Goldstein SR. Bleeding patterns in perimenopausal women. Reduction of breast cancer risk in midlife

women. Chapters in Textbook of Perimenopausal Gynecology. Editors: Santoro N, Goldstein SR. Parthenon

Publishing, London 2003

Santoro N, Goldstein SR. Textbook of Perimenopausal Gynecology. Parthenon Publishing, London 2003

Goldstein SR. Early Pregnancy Failure. Chapter 34 in Ultrasound and Endoscopic Surgery in Obstetrics and

Gynaecology Editors: Timmerman D, Deprest J, Bourne T. Springer-Verlag, London 2003

Goldstein SR Menorrhagia and abnormal bleeding before the menopause. Best Pract Res Clin Obstet

Gynaecol Special issue: Ultrasound in Gynaecology 2004;18:59-69. Review.

Goldstein SR. Abnormal uterine bleeding: the role of ultrasound. Chapter in Ultrasound Clinics. Editors:

Deborah Levine, M.D., Ruth B. Goldstein, M.D. Elsevier Saunders 2006

Goldstein SR. Abnormal uterine bleeding: the role of ultrasound. Radiol Clin North Am. 2006;44:901-

910. Review.

Goldstein SR. The diagnosis of miscarriage. Handbook of Early Pregnancy Care. Editors: Tom Bourne,

M.D., George Condous, M.D. Taylor & Francis 2006

Goldstein SR, Timor-Tritsch IE. Ultrasound in Gynecology. Second Edition Churchill Livingstone Inc. 2007

Goldstein SR, Editor. Ultrasound scanning in reproductive medicine and Infertility in Seminars in

Reproductive Medicine. Thieme 2008

Goldstein SR. Early pregnancy: normal and abnormal. Semin Reprod Med. 2008;26:277-83. Review.

Steven R. Goldstein, MD, & Matthew F. Reeves, MD, MPH, Clinical Assessment and Ultrasound in Early

Pregnancy, in Management of Unintended and Abnormal Pregnancy: Comprehensive Abortion Care 63–77

(Maureen Paul, MD, MPH, et al. eds. 2009).

31

Goldstein SR, Duvernoy CS, Calaf J, Adachi JD, Merson JL, Dowsett SA, Afnusdei D, Stuenkel CA.

Raloxifene use in clinical practice: Efficacy and Safety. Menopause. 2009;16:413-21. Review

Goldstein SR. Modern evaluation of the endometrium. Obstet Gynecol. 2010;116:168-76.

Levine D, Brown DL, Andreotti RF, Benacerraf B, Benson CB, Brewster WR, Coleman B, DePriest P,

Doubilet PM, Goldstein SR, Hamper UM, Hecht JL, Horrow M, Hur HC, Marnach M, Patel MD, Platt

LD, Puscheck E, Smith-Bindman R. Management of asymptomatic ovarian and other adnexal cysts

imaged at US: Society of Radiologists in Ultrasound consensus conference statement. Ultrasound Q.

2010;26:121-31. Review.

Levine D, Brown DL, Andreotti RF, Benacerraf B, Benson CB, Brewster WR, Coleman B, DePriest P,

Doubilet PM, Goldstein SR, Hamper UM, Hecht JL, Horrow M, Hur HC, Marnach M, Patel MD, Platt

LD, Puscheck E, Smith-Bindman R. Management of asymptomatic ovarian and other adnexal cysts

imaged at US: Society of Radiologists in Ultrasound consensus conference statement. Radiology.

2010;256:943-54. Review.

Goldstein SR. Significance of incidentally think endometrial echo on transvaginal ultrasound in

postmenopausal women. Menopause. 2011;18:434-6. Review.

Lerner VT, Goldstein SR, Timor-Tritsch IE. Abnormal uterine sac. Chapter in Obstetrics Imaging.

Editors: Saunders, 2012.

Goldstein SR. Sonography in postmenopausal bleeding. J Ultrasound Med. 2012;31:333-6. Review.

Goldstein SR. Low-dose aspirin in pregnancy. The Medical Letter On Drugs and Therapeutics.

2014;1445. Review.

Blanchette Porter M, Goldstein SR. Yen and Jaffe’s Reproductive Endocrinology: Physiology,

Pathophysiology, and Clinical Management Eighth Edition. Pelvic imaging in reproductive endocrinology;

Chapter 35. Strauss, Barbieri, eds. Elsevier, Pennsylvania 2018.

Khafaga A, Goldstein SR. Menstrual Cycle related Disorders: Volume 7: Frontiers in Gynecological

Endocrinology. Diagnosing Abnormal Uterine Bleeding: The Standard of Care Has Changed; Chapter 9.

Berga, Genazzani, Naftolin, Petraglia, eds. Springer, Switzerland.

Goldstein SR. Abnormal Uterine Bleeding. In: Menopause Practice: A clinician’s Guide. Pepper Pike, OH:

The North American Menopause Society; 2019:93-100.

Khafaga A, Goldstein SR. Ultrasonography in Gynecology and Early Pregnancy: Volume 46, Number 4.

Abnormal Uterine Bleeding; Platt and Han eds. Elsevier, Pennsylvania 2019:595-605.

Goldstein, SR. The IMS: charting a course forward. Climacteric; 2020;23(6):528-529.

PUBLISHED ABSTRACTS:

http://www.ncbi.nlm.nih.gov/pubmed/20823748http://www.ncbi.nlm.nih.gov/pubmed/20823748http://www.ncbi.nlm.nih.gov/pubmed/20823748http://www.ncbi.nlm.nih.gov/pubmed/20823748

32

Goldstein SR. The Many Faces of the Pelvis: Normal Physiology as Seen With Ultrasound. J Ultrasound

Med 15:K"S" 22-23, 1996.

Goldstein SR., Zeltser I, Horan C, et al. Transvaginal ultrasound and saline infusion sonohysterography can

lower healthcare costs associated with abnormal perimenopausal bleeding. J Ultrasound Med 15:K"S" 30-31,

1996.

Goldstein SR, Schwartz L, Snyder JS, et al. Screening and monitoring endometrial response to tamoxifen

therapy for breast cancer. J Ultrasound Med 15:K"S" 31-32, 1996.

Goldstein SR, Scheele WH, Symanowski SM, Neale S, Shah A, Lafortune M, Fugere P. Uterine Safety

Considerations for Selective Estrogen Receptor Modulators. Menopause 4:250, 1997.

Goldstein SR, DeZiegler D. Vaginal Progesterone in Hormone Replacement Therapy (HRT): Experience

with the Vaginal Gel Crinone 4% in Peri- and Post-menopausal Women. Menopause 1999; 6:375

Calle PP, Goldstein SR, Grunfeld L, et al. Comparison of transabdominal, transvaginal, and transrectal

ultrasound examinations of seven female western lowland gorillas (Gorilla gorilla gorilla) 2000 Proceedings

AAZV and IAAAM Joint Conference; 171-172

Goldstein SR, Johnson S, Mason TM, Elmrick D, Mershon J. Incidence of vaginal bleeding among

postmenopausal women taking raloxifene vs. placebo. Menopause 2002;9:489.

Timor-Tritsch I, Goldstein SR, Masch R. TUAGS (transvaginal ultrasound assisted gynecological surgery): a

new technique to improve uterine surgery. Ultrasound Med Biol. 2003;29:S52.

Goldstein SR. Ultrasound-based triage for abnormal uterine bleeding. Ultrasound Med Biol. 2003 May;29(5

Suppl):S36.

Goldstein SR. Early Detection Ovarian Cancer: Is it screening? J Ultrasound Med 2006;25:S1

Goldstein SR, Cummings SR, Eastell R, Ensrud K, et al. Vaginal effects of lasofoxifene: 3 year results from

the PEARL

Trial. North American Menopause Society. September 200815:1228

Goldstein SR, Timor-Tritsch I, Monda S, Popliolek D, Monteagudo A. Ultrasound appearance of

cystadenofibroma: can we reduce surgical intervention? Ultrasound in Obstet Gynecol. 2009;34 (Suppl.1):1-

6.

Goldstein SR, Sriram U, Neven P, Colgan T, Runowicz C, Krpan D, Giljevic Z, Cumming S, Proulx J,

Johnson M, Thompson D. Postmenopausal Evaluation and risk-reduction with lasofoxifene (the Pearl Trial):

Gynaecological outcomes at five-years. 8th European Congress on Menopause (EMAS) May, 2009

Goldstein SR. Improving patient management with transvaginal ultrasound in the evaluation and

management of abnormal uterine bleeding. American Institute of Ultrasound in Medicine. October, 2009

33

Lyons E, Goldstein SR, Tirabassi M, Munro M, Toub D. Intrauterine Ultrasound: A new imaging modality

for intramyometrial pathology. Gynesonics AAGL Annual Meeting November, 2009.

Goldstein SR. Pregnancies of unknown locations (PULS) and beyond. J Ultrasound Med 2011;30:S53.

Goldstein SR. Is percentile body fat by dual-energy x-ray absorptiometry a better surrogate for metabolic

health than body mass index? Obstetrics and Gynecology 2015; 100S.

Goldstein SR, Portman D, Symons J. Endometrial effects of lasofoxifene: Results from two phase 3

osteoporosis prevention trials. 26th Annual Meeting of The North American Menopause Society. Menopause

2015: 22(12);1372.

Goldstein SR, Mischoulon D. Does Relizen, a non-hormonal treatment for the relief of menopausal hot

flashes work through a serotonergic mechanism of action. 26th Annual Meeting of The North American

Menopause Society. Menopause 2015: 22(12);1383.

Goldstein SR, Kagan R. Incidence of bleeding or spotting with a conjugated estrogen/Bazedoxifene

compound compared to conjugated estrogen/progestogen to placebo. 26th Annual Meeting of The North

American Menopause Society. Menopause 2015: 22(12);1384.

Goldstein SR, Hirsch J, Oh C, Nachtigall R, Nachtigall L. DXA assessment of adiposity is a better predictor

of metabolic risk than BMI. 26th Annual Meeting of The North American Menopause Society. Menopause

2015: 22(12);1397.

Esposito DB, Yin R, Russo LJ, del Carmen MG, Goldstein SR, Patsner B, Lanes SF. Development and

validation of an algorithm to identify endometrial adenocarcinoma in US Administrative Claims data.

Pharmacoepidemiology & drug safety 2016;25:159-60 [Meeting Abstract].

Esposito DB, Yin R, Russo LJ, Ridgeway G, Finkle W, Goldstein SR, Mittal K, Walsh BW, Lanes SF.

Development and validation of an algorithm to identify endometrial hyperplasia in US Administrative

Claims data. Pharmacoepidemiology & drug safety 2016;25:160 [Meeting Abstract].

Catherino W, Eisenhut C, Blakesley R, Chan A, Sniukiene V, Goldstein SR. Treatment of Symptomatic

Uterine Fibroids with Ulipristal Acetate: Endometrial Safety. Modern pathology 2017; 30:279A (# 2517602)

[Meeting Abstract]

Goldstein SR. Evaluation of postmenopausal bleeding: What is the standard of care? 28th Annual Meeting

of The North American Menopause Society. Menopause 2017:24(12);1420 [Meeting Abstract]

Goldstein SR; Constantine G, Archer DF, Pickar JH, Graham S, Bernick B, Mirkin S. Effects of TX-

001HR on uterine bleeding rates in menopausal women with vasomotor symptoms. 28th Annual Meeting

of The North American Menopause Society. Menopause 2017:24(12);1431-1432. [Meeting Abstract]

34

Goldstein SR, Veledar E, Ojalvo SP, Komorowski JR. Patient Satisfaction with the Use of Relizen to

Treat Menopausal Symptoms. 28th Annual Meeting of The North American Menopause Society.

Menopause 2017;24:1455-1455. [Meeting Abstract]

Archer D, Goldstein SR, Simon J, Waldbaum A, Sussman S, Altomare C, Zhu J, Yoshida Y, Schaffer S,

Soulban G. Efficacy and safety of ospemifene in menopausal women with moderate to severe vaginal

dryness: A phase 3, randomized double-blind placebo-controlled multicenter clinical trial. 29th Annual

Meeting of The North American Menopause Society. Menopause. 2018;25(12)1501. [Meeting Abstract]

Goldstein SR. Modern evaluation of abnormal uterine bleeding. Maturitas. 2019 European Menopause and

Andropause Society. DOI: 10.1016/j.Maturitas.2019.04.035. [Meeting Abstract]

Goldstein, S. SERMs: past and present. Maturitas. 2019 Annual Meeting European Menopause and Andropause Society. DOI: 10.1016/j.Maturitas.2019.04.053. [Meeting Abstract]

Leonardi, M; Goldstein, SR; Benacceraf, B; Condous, G. 1829 Current State of Pelvic Ultrasound for

Endometriosis: Results of an International Survey. 2019 American Association of Gynecologic

Laparoscopists: Journal of Minimally Invasive Gynecology.S184-S185 (# 4137402) [Meeting Abstract]

Pickar JH, Archer DF, Goldstein, SR, Kagan R, Bernick B, Mirkin S. Uterine Bleeding Rates with

Hormone Therapies in Menopausal Women with Vasomotor Symptoms. 30th Annual Meeting of The

North American Menopause Society. Menopause. 2019; 26(12);1475. [Meeting Abstract].

Kingsberg S, Marubayashi F, Goldstein S, Simoncini T, Nakanishi N, Ogasawara A, Kakinoki B, Khan S. A

clinical study to evaluate Elismetrep (TRPM8 antagonist), a non-hormonal drug for the treatment of

vasomotor symptoms in postmenopausal women. Menopause. 31st Annual Meeting of The North American

Menopause Society. Menopause. 2020:27(12);1458. [Meeting Abstract]

Goldstein SR, Archer DF, Graham S, Bernick B, Mirkin S. The Effects of a 17β-estradiol, Softgel, Vaginal

Insert on Vulvar and Vaginal Atrophy (VVA), Including Moderate to Severe Dyspareunia and Vaginal

Dryness in Postmenopausal Women > 60 Years of Age. 31st Annual Meeting of The North American

Menopause Society. Menopause. 2020:27(12);1465-6. [Meeting Abstract]

OTHER PUBLICATIONS:

Goldstein SR. Vaginal probe ultrasonography and ectopic pregnancy (Letter/Comment). Am J Obstet

Gynecol 163:1099-1100, 1990.

Goldstein SR. Early pregnancy failure - appropriate terminology (Letter/Comment). Am J Obstet Gynecol

163:1093, 1990.

Goldstein SR. Transvaginal sonographic detection of the pseudogestational sac associated with ectopic

pregnancy (Letter/Comment). Obstet Gynecol 76:892-3, 1990.

35

Goldstein SR. Increasing use of gynecologic ultrasonography (Letter/Comment). Am J Obstet Gynecol

166:4;1310-1, 1992.

Goldstein SR. Ultrasonographic evaluation of patients with abnormal bleeding (Letter/Comment). Am J

Obstet Gynecol 173:1351- 2, 1995.

Goldstein SR. Reprocessing of the vaginal probe between patients (Opinion). Ultrasound Obstet Gynecol

7:92-93, 1996.

Goldstein SR. Endometrial fluid accumulation in postmenopausal women (Letter/Comment).

Ultrasound Obstet Gynecol 8:429, 1996.

Goldstein SR, The presence of endometrial fluid in asymptomatic postmenopausal women is associated

with clinically relevant cervical stenosis [letter; comment], Journal of Ultrasound In Medicine, 16(3), 208,

Mar 1997.

Goldstein S R, Endometrial changes assessed by transvaginal sonography [letter], Journal of Clinical

Ultrasound, 26(5), 280-1, Jun 1998.

Goldstein S R, Endometrial safety during hormone replacement therapy: comparison of transvaginal

sonography and endometrial biopsy [letter], Menopause, 5(2), 132-3, 1 Jul 1998.

Goldstein SR. Effect of Raloxifene on the endometrium: Will this be the ultimate key to its utilitization?

(Editorial). Menopause 1999;6:183-5.

Goldstein SR. Further attempts to refine our diagnostic capabilities in potential ectopic pregnancies.

(Opinion) Am J Obstet Gynecol 1999;14:229-230

Goldstein SR. Controversy about uterine effects and safety of SERMs: the saga continues. (Personal

Perspective) Menopause 2002;9:381-384.

Goldstein SR. Not all SERMs are created equal. (Editorial) Menopause 2006;13:325-327

Goldstein SR. Not all SERMs are created equal: Update on lasofoxifene International Journal of

Gynecological Cancer. 2006;16 Suppl 2:504.

Goldstein SR. Attempt to reduce the progestrogen component in hormone therapy. (Letter)Menopause

2006;13:538.

Goldstein SR. Raloxifene vs tamoxifen. (Letter) JAMA 2007;297:263-4.

Goldstein SR. Predicting uterine weight before hysterectomy: ultrasound measurements vs clinical

assessment. Am J Obstet Gynecol 2007;196:e16. (Letter)

36

Goldstein SR. To the editor. Use of transvaginal ultrasonography and sonohysterography. (Author reply)

Menopause. 2008;15(2):402;403-4.

Goldstein SR. Abnormal uterine bleeding: transvaginal ultrasound or endometrial biopsy? ASUM

2008;11:15-17 (Opinion)

Goldstein SR. Not all SERMs are created equal: Chapter 2. (Editorial) Menopause 2015;22:802-803.

Goldstien SR. Letter to the editor. Menopause 2015;22:475-475.

Goldstein SR. The conundrum of asymptomatic adnexal masses: a clinician’s opinion. Am J Obstet Gynecol

2016;4:422-3

INVITED SPEAKER:

Faculty Member

New York University Postgraduate Medical School

"Office Obstetrical Ultrasound - An 8 Week Tutorial"

New York, New York

1982-1984

Faculty Member


The Department of Obstetrics and Gynecology

"The Ultrasound Revolution in Obstetrics"

New York, New York

June 1982

Course Director, Faculty Member



"Basic and Advanced Obstetrical Ultrasound"

New York, New York

June 1983

Lecturer

New York University School of Diagnostic Ultrasound

New York, New York

1984




"Third Annual Obstetrical Ultrasound Course”

37

New York, New York

June 1984

Program Participant

American College of Obstetrics and Gynecology


"Are we doing amniocentesis on the right people for the right reasons?"

1984

Faculty Member


The Department of Radiology Ultrasound Course

New York, New York

October 1984

Faculty Member

Case Western Reserve Medical School and

Cleveland Metropolitan Hospital Course

"Advanced Ultrasound"

Cleveland, Ohio

April 1985




"Fourth Annual Basic Obstetrical Ultrasound Seminar"

New York, New York

June 1985

Faculty Member


Postgraduate Course

"Basic Ultrasound"

Atlantic City, New Jersey

August 1985

Faculty Member


The Department of Radiology

Ultrasound Course

New York, New York

October 1985


Department of Radiology

Resident Lecture Series

38

New York, New York

1985

Program Participant


Original Ob-Gyn Paper Presentation

"Combined Sonographic-Pathologic Surveillance in Elective First Trimester

Terminations"

October 1986

"Stump The Professors", Film Panelist


October 1986

Program Participant



"Pregnancy Termination Surveillance - Is Ultrasound the Answer?

April 1987

Faculty Member

New York State Diagnostic Medical Sonographer's Course

May 1987




"Fifth Annual Obstetrical Ultrasound Seminar"

June 1987

Grand Rounds Speaker

Jersey Shore Medical Center

"Early Pregnancy Scanning"

September 1987

Meet The Professors Session



October 1987

Scientific Exhibitor


Annual Meeting

"Very Early Pregnancy Detection with Intravaginal Ultrasound"

October 1987

39

Guest Lecturer

New York State Society of Diagnostic Medical Sonographers

"The Endovaginal Approach to Early Pregnancy"

October 1987

Faculty Member

Mt. Sinai School of Medicine Course

"Endovaginal Ultrasound: It's Application for IVF and Gynecology"

New York, New York

November 1987

Grand Rounds

Cornell University - N.Y. Hospital



New York, New York

November 1987

Faculty Member

Columbia University College of Physicians and Surgeons

"Transvaginal Sonography: Clinical Applications"

New York, New York

March 1988

Faculty Member

The International Association for Endosonography

"Endovaginal Sonography"

Orlando, Florida

March 1988

Faculty Member


The Department of Ob-Gyn

"Menopausal Estrogens"

April 1988

Program Participant

American College of Gynecology


Origi

Date post:	24-Oct-2020
Category:	Documents
Upload:	others
View:	1 times
Download:	0 times

NAME: Steven R. Goldstein, M.D.€¦ · NAME: Steven R. Goldstein, M.D. BUSINESS ADDRESS: 530 First...

Documents